Literature DB >> 32139596

Role of Proinsulin Self-Association in Mutant INS Gene-Induced Diabetes of Youth.

Jinhong Sun1, Yi Xiong1, Xin Li2, Leena Haataja1, Wei Chen1,3, Saiful A Mir4, Li Lv2, Rachel Madley1, Dennis Larkin1, Arfah Anjum1, Balamurugan Dhayalan5, Nischay Rege6, Nalinda P Wickramasinghe6, Michael A Weiss5, Pamela Itkin-Ansari4,7, Randal J Kaufman8, David A Ostrov9, Peter Arvan10, Ming Liu10,2.   

Abstract

Abnormal interactions between misfolded mutant and wild-type (WT) proinsulin (PI) in the endoplasmic reticulum (ER) drive the molecular pathogenesis of mutant INS gene-induced diabetes of youth (MIDY). How these abnormal interactions are initiated remains unknown. Normally, PI-WT dimerizes in the ER. Here, we suggest that the normal PI-PI contact surface, involving the B-chain, contributes to dominant-negative effects of misfolded MIDY mutants. Specifically, we find that PI B-chain tyrosine-16 (Tyr-B16), which is a key residue in normal PI dimerization, helps confer dominant-negative behavior of MIDY mutant PI-C(A7)Y. Substitutions of Tyr-B16 with either Ala, Asp, or Pro in PI-C(A7)Y decrease the abnormal interactions between the MIDY mutant and PI-WT, rescuing PI-WT export, limiting ER stress, and increasing insulin production in β-cells and human islets. This study reveals the first evidence indicating that noncovalent PI-PI contact initiates dominant-negative behavior of misfolded PI, pointing to a novel therapeutic target to enhance PI-WT export and increase insulin production.
© 2020 by the American Diabetes Association.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32139596      PMCID: PMC7171958          DOI: 10.2337/db19-1106

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  37 in total

1.  I222 crystal form of despentapeptide (B26-B30) insulin provides new insights into the properties of monomeric insulin.

Authors:  Jean L Whittingham; Zhang Youshang; Lenka Záková; Eleanor J Dodson; Johan P Turkenburg; Jens Brange; G Guy Dodson
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2006-04-19

2.  Semisynthesis and properties of some insulin analogs.

Authors:  K Inouye; K Watanabe; Y Tochino; M Kobayashi; Y Shigeta
Journal:  Biopolymers       Date:  1981-09       Impact factor: 2.505

3.  Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis.

Authors:  Intza Garin; Emma L Edghill; Ildem Akerman; Oscar Rubio-Cabezas; Itxaso Rica; Jonathan M Locke; Miguel Angel Maestro; Adnan Alshaikh; Ruveyde Bundak; Gabriel del Castillo; Asma Deeb; Dorothee Deiss; Juan M Fernandez; Koumudi Godbole; Khalid Hussain; Michele O'Connell; Thomasz Klupa; Stanislava Kolouskova; Fauzia Mohsin; Kusiel Perlman; Zdenek Sumnik; Jose M Rial; Estibaliz Ugarte; Thiruvengadam Vasanthi; Karen Johnstone; Sarah E Flanagan; Rosa Martínez; Carlos Castaño; Ann-Marie Patch; Eduardo Fernández-Rebollo; Klemens Raile; Noel Morgan; Lorna W Harries; Luis Castaño; Sian Ellard; Jorge Ferrer; Guiomar Perez de Nanclares; Andrew T Hattersley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-28       Impact factor: 11.205

4.  Chemical synthesis of insulin analogs through a novel precursor.

Authors:  Alexander N Zaykov; John P Mayer; Vasily M Gelfanov; Richard D DiMarchi
Journal:  ACS Chem Biol       Date:  2014-01-02       Impact factor: 5.100

5.  ERO1-beta, a pancreas-specific disulfide oxidase, promotes insulin biogenesis and glucose homeostasis.

Authors:  Ester Zito; King-Tung Chin; Jaime Blais; Heather P Harding; David Ron
Journal:  J Cell Biol       Date:  2010-03-22       Impact factor: 10.539

Review 6.  Misfolded proinsulin in the endoplasmic reticulum during development of beta cell failure in diabetes.

Authors:  Anoop Arunagiri; Leena Haataja; Corey N Cunningham; Neha Shrestha; Billy Tsai; Ling Qi; Ming Liu; Peter Arvan
Journal:  Ann N Y Acad Sci       Date:  2018-01-28       Impact factor: 5.691

7.  Control of precursor maturation and disposal is an early regulative mechanism in the normal insulin production of pancreatic β-cells.

Authors:  Jie Wang; Ying Chen; Qingxin Yuan; Wei Tang; Xiaoping Zhang; Kwame Osei
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

8.  Intracellular transport and sorting of mutant human proinsulins that fail to form hexamers.

Authors:  D Quinn; L Orci; M Ravazzola; H P Moore
Journal:  J Cell Biol       Date:  1991-06       Impact factor: 10.539

9.  IRE1-XBP1 pathway regulates oxidative proinsulin folding in pancreatic β cells.

Authors:  Yuichi Tsuchiya; Michiko Saito; Hiroshi Kadokura; Jun-Ichi Miyazaki; Fumi Tashiro; Yusuke Imagawa; Takao Iwawaki; Kenji Kohno
Journal:  J Cell Biol       Date:  2018-03-05       Impact factor: 10.539

10.  Proinsulin misfolding is an early event in the progression to type 2 diabetes.

Authors:  Anoop Arunagiri; Leena Haataja; Anita Pottekat; Fawnnie Pamenan; Soohyun Kim; Lori M Zeltser; Adrienne W Paton; James C Paton; Billy Tsai; Pamela Itkin-Ansari; Randal J Kaufman; Ming Liu; Peter Arvan
Journal:  Elife       Date:  2019-06-11       Impact factor: 8.140

View more
  12 in total

1.  Predisposition to Proinsulin Misfolding as a Genetic Risk to Diet-Induced Diabetes.

Authors:  Maroof Alam; Anoop Arunagiri; Leena Haataja; Mauricio Torres; Dennis Larkin; John Kappler; Niyun Jin; Peter Arvan
Journal:  Diabetes       Date:  2021-08-30       Impact factor: 9.461

2.  Novel Pathogenic De Novo INS p.T97P Variant Presenting With Severe Neonatal DKA.

Authors:  Rayhan A Lal; Hannah P Moeller; Ella A Thomson; Timothy M Horton; Sooyeon Lee; Raquel Freeman; Priya Prahalad; Ada S Y Poon; Justin P Annes
Journal:  Endocrinology       Date:  2022-02-01       Impact factor: 5.051

3.  Evolution of insulin at the edge of foldability and its medical implications.

Authors:  Nischay K Rege; Ming Liu; Yanwu Yang; Balamurugan Dhayalan; Nalinda P Wickramasinghe; Yen-Shan Chen; Leili Rahimi; Huan Guo; Leena Haataja; Jinhong Sun; Faramarz Ismail-Beigi; Nelson B Phillips; Peter Arvan; Michael A Weiss
Journal:  Proc Natl Acad Sci U S A       Date:  2020-11-05       Impact factor: 11.205

Review 4.  Normal and defective pathways in biogenesis and maintenance of the insulin storage pool.

Authors:  Ming Liu; Yumeng Huang; Xiaoxi Xu; Xin Li; Maroof Alam; Anoop Arunagiri; Leena Haataja; Li Ding; Shusen Wang; Pamela Itkin-Ansari; Randal J Kaufman; Billy Tsai; Ling Qi; Peter Arvan
Journal:  J Clin Invest       Date:  2021-01-19       Impact factor: 14.808

Review 5.  Diabetes-Associated Mutations in Proinsulin Provide a "Molecular Rheostat" of Nascent Foldability.

Authors:  Balamurugan Dhayalan; Michael A Weiss
Journal:  Curr Diab Rep       Date:  2022-02-04       Impact factor: 4.810

6.  Defects in Protein Folding and/or Quality Control Cause Protein Aggregation in the Endoplasmic Reticulum.

Authors:  Juthakorn Poothong; Insook Jang; Randal J Kaufman
Journal:  Prog Mol Subcell Biol       Date:  2021

7.  The KINGS Ins2 +/G32S Mouse: A Novel Model of β-Cell Endoplasmic Reticulum Stress and Human Diabetes.

Authors:  Amazon L F Austin; Lydia F Daniels Gatward; Miriam Cnop; Gabriel Santos; David Andersson; Sally Sharp; Clive Gentry; Stuart Bevan; Peter M Jones; Aileen J F King
Journal:  Diabetes       Date:  2020-09-29       Impact factor: 9.461

8.  A Novel Nonsense INS Mutation Causes Inefficient Preproinsulin Translocation Into the Endoplasmic Reticulum.

Authors:  Ying Yang; Hua Shu; Jingxin Hu; Lei Li; Jianyu Wang; Tingting Chen; Jinyang Zhen; Jinhong Sun; Wenli Feng; Yi Xiong; Yumeng Huang; Xin Li; Kai Zhang; Zhenqian Fan; Hui Guo; Ming Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2022-01-05       Impact factor: 5.555

Review 9.  Protein Aggregation in the ER: Calm behind the Storm.

Authors:  Haisen Li; Shengyi Sun
Journal:  Cells       Date:  2021-11-28       Impact factor: 7.666

10.  Distinct states of proinsulin misfolding in MIDY.

Authors:  Leena Haataja; Anoop Arunagiri; Anis Hassan; Kaitlin Regan; Billy Tsai; Balamurugan Dhayalan; Michael A Weiss; Ming Liu; Peter Arvan
Journal:  Cell Mol Life Sci       Date:  2021-07-10       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.